Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Pariet receives E.U. approval for H. pylori eradication in peptic ulcer disease

Nov. 14, 2000

Trimetazidine analogue exerts significant hepatoprotective effects in I/R injury model in rats

Nov. 13, 2000

Novel peptides for HCV infection emerge from R&D at Boehringer Ingelheim

Nov. 10, 2000

Significant reduction in HBV DNA obtained on adefovir dipivoxil in lamivudine-resistant HBV patients

Nov. 10, 2000

Major breakthrough in HBV therapy reported at AASLD

Nov. 10, 2000

Addition of oprelvekin allows completion of full-dose therapy for hepatitis C

Nov. 9, 2000

Enzo Biochem's oral HBV protein product highlighted at AASLD meeting

Nov. 8, 2000

Cilansetron moves into phase III for IBS

Nov. 8, 2000

Recent patent covers Bayer's newest agents for HBV

Nov. 7, 2000

Heptazyme, an exciting new approach to chronic hepatitis C, covered at AASLD

Nov. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...